← FDA Drug Approvals (Drugs@FDA)

LAMOTRIGINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IMPAX LABS INC · Approved 2013-07-15

Drug application

FDA Application #
ANDA200828
Application type
Abbreviated New Drug Application (Generic)
Brand name
LAMOTRIGINE
Generic name
LAMOTRIGINE
Active ingredients
LAMOTRIGINE
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Marketing status
Prescription
Sponsor
IMPAX LABS INC
Manufacturer
Amneal Pharmaceuticals of New York LLC
First approval
2013-07-15

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown